3D Microarray Surface for Glucose Transporter Screening

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current efforts to develop potent and isoform-specific inhibitors for glucose transporters, particularly GLUT1, have not resulted in clinical candidates, despite numerous reported inhibitors, due to challenges in identifying effective compounds that can target cancer cells effectively.

Innovation Solution

A three-dimensional microarray is developed with surface-modified substrates having polymer chains with diazirine functional groups and rapafucins covalently bound, allowing for the immobilization of small molecules and proteins, enabling the screening for glucose transporter inhibitors, such as rapaglutin A (RgA), which binds to GLUT1, GLUT3, and GLUT4, inhibiting glucose uptake and inducing apoptosis in cancer cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional two-dimensional surfaces are used for microarrays, then the structure is simple and easy to manufacture, but the binding capacity and screening effectiveness for glucose transporter inhibitors are insufficient

Engineering Contradiction:
Improvescreening effectivenessVSAvoidsurface structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent transitions from traditional two-dimensional planar surfaces to three-dimensional hierarchical microarray structures. This dimensional change increases the surface area and binding capacity, allowing more small molecules to be immobilized per unit area, thereby improving screening effectiveness for glucose transporter inhibitors while maintaining structural feasibility through controlled hierarchical organization.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The patent implements nested hierarchical structures where microarrays are organized into multiple levels of organization. Small molecules are immobilized on support structures that are themselves organized in hierarchical arrangements, creating a nested configuration that maximizes binding capacity within a compact volume, thus improving screening effectiveness without excessive complexity.

Inventive Principle:
Principle #7Nested doll (Nesting)

2Quantity of substance

If more small molecules are immobilized on the microarray surface, then the screening capacity increases, but the binding sites become crowded reducing accessibility for target proteins

Engineering Contradiction:
Improvenumber of small moleculesVSAvoidprotein accessibility
Core Design Contradiction:
Quantity of substanceVSEase of operation

Solution Approach 1:

The patent applies local quality by creating heterogeneous distributions of small molecules within the microarray structure. Different regions of the hierarchical structure have optimized local densities and compositions, ensuring that small molecules are spaced appropriately to maintain accessibility for target proteins while achieving high overall capacity. This local optimization allows dense packing without sacrificing binding accessibility.

Inventive Principle:
Principle #3Local quality

3Stability of the object's composition

If covalent binding is used to immobilize small molecules, then the immobilization is stable and permanent, but the binding process requires additional steps and time

Engineering Contradiction:
Improveimmobilization stabilityVSAvoidimmobilization time
Core Design Contradiction:
Stability of the object's compositionVSLoss of time

Solution Approach 1:

The patent employs preliminary action by pre-functionalizing the small molecules with reactive groups that enable direct covalent attachment to the microarray support structures. This pre-preparation of reactive moieties on small molecules allows for rapid one-step immobilization without requiring subsequent coupling reactions, thus achieving stable covalent binding while minimizing the time required for the immobilization process.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Rapaglutin A effectively inhibits glucose uptake, activates AMPK, inhibits mTOR signaling, and induces cell cycle arrest and apoptosis in cancer cells, demonstrating potential as a therapeutic agent for cancer treatment by targeting multiple glucose transporter isoforms.

Implementation Method 1

exposing the printed library of small molecules to UV light of an appropriate wavelength to cause crosslinking of the small molecules to the surface through photoactivation of the one or more diazirine functional groups into one or more reactive carbene species

Methodology Applied
Scientific EffectPhotoactivation: Photo-oxidation

Data Source

PatentUS20240024410A1Three-dimentional surface for protein and small molecule microarrays
Publication Date: 2024.01.25 JOHNS HOPKINS UNIVERSITY
  • US20240024410A1 patent drawing
  • US20240024410A1 patent drawing
  • US20240024410A1 patent drawing

AI summary

Surface structures that enable the preparation of three-dimensional microarrays of proteins or small molecules or other types of macromolecules are disclosed. The three-dimensional microarrays possess higher sensitivity for detecting protein-macromolecule and small molecule-protein interactions in a high-throughput fashion.